When people hear “ALS,” they often think of Lou Gehrig, ice bucket challenges, and the devastating loss of motor function that…

The Association for Frontotemporal Degeneration (AFTD) has shared that two drugs have been selected for evaluation in a new platform trial aimed at accelerating the development of treatments for progressive supranuclear palsy (PSP).

548 participants responded to the FTD Disorders Registry’s April Quick Question on accessing respite care.

Data from the FTD Disorders Registry was presented in three posters at the April 2025 Annual Meeting of the American Academy of Neurology (AAN) in San Diego, CA.